PT Merck Tbk (IDX:MERK)

Market Cap	1.53T
Revenue (ttm)	934.62B
Net Income (ttm)	124.26B
Shares Out	448.00M
EPS (ttm)	277.37
PE Ratio	12.29
Forward PE	n/a
Dividend	320.00 (9.38%)
Ex-Dividend Date	Jun 7, 2024

Volume	5,000
Average Volume	8,915
Open	3,320.00
Previous Close	3,320.00
Day's Range	3,300.00 - 3,420.00
52-Week Range	3,080.00 - 4,400.00
Beta	0.47
RSI	55.35
Earnings Date	Apr 30, 2025

About PT Merck Tbk

PT Merck Tbk engages in the manufacture and sale of pharmaceutical products in Indonesia and internationally. The company operates through three segments: Biopharma, Consumer Health, and Others. It offers health care products in the areas of cardiovascular, metabolic, oncology, endocrinology, fertility, and neurodegenerative diseases, as well as general medicines. The company also engages in research an, development, production, and distribution of pharmaceutical and biological prescription medicines to treat colorectal cancer, head and neck ca...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1970
• Employees: 372
• Stock Exchange: Indonesia Stock Exchange
• Ticker Symbol: MERK

Financial Performance

In 2023, PT Merck Tbk's revenue was 961.43 billion, a decrease of -14.51% compared to the previous year's 1.12 trillion. Earnings were 178.24 billion, a decrease of -0.89%.